Published in J Urol on July 17, 2008
Changing practice locations for upper urinary tract stone disease. J Urol (2009) 1.13
Epidemiology of spine care: the back pain dilemma. Phys Med Rehabil Clin N Am (2010) 0.96
High and rising health care costs. Part 1: seeking an explanation. Ann Intern Med (2005) 4.98
The effect of physician-owned surgicenters on hospital outpatient surgery. Health Aff (Millwood) (2002) 1.23
Prospective payment. Some retrospective observations. N Engl J Med (1988) 1.11
Ambulatory surgery centers--current business and legal issues. J Health Care Finance (2000) 1.01
Medicare program; revised payment system policies for services furnished in ambulatory surgical centers (ASCs) beginning in CY 2008. Final rule. Fed Regist (2007) 1.01
Changing patterns of surgical care in the United States, 1980-1995. Health Care Financ Rev (1999) 0.99
Specialty versus community hospitals: what role for the law? Health Aff (Millwood) (2007) 0.88
Medicare program; ambulatory surgical services--Health Care Financing Administration. Final rule. Fed Regist (1982) 0.85
Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58
Integrative molecular concept modeling of prostate cancer progression. Nat Genet (2006) 8.49
Autoantibody signatures in prostate cancer. N Engl J Med (2005) 7.56
Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst (2006) 6.58
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell (2005) 6.04
Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet (2006) 5.65
Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst (2006) 5.42
Imaging use among employed and self-employed urologists. J Urol (2010) 5.34
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res (2006) 4.99
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
Hospital lymph node examination rates and survival after resection for colon cancer. JAMA (2007) 4.55
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med (2006) 4.09
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol (2006) 3.76
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol (2007) 3.37
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res (2008) 3.35
National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology (2006) 3.34
Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia. Urology (2013) 3.31
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA (2013) 3.08
The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell (2008) 2.87
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol (2005) 2.84
The increasing incidence of newborn circumcision: data from the nationwide inpatient sample. J Urol (2005) 2.76
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70
Physician-ownership of ambulatory surgery centers linked to higher volume of surgeries. Health Aff (Millwood) (2010) 2.68
Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) (2012) 2.67
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med (2011) 2.62
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res (2009) 2.51
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia (2006) 2.39
Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol (2004) 2.39
Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol (2012) 2.37
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev (2010) 2.36
Nocturia and quality of life: results from the Boston area community health survey. Eur Urol (2011) 2.34
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys (2006) 2.33
NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw (2010) 2.31
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab. Cancer Res (2013) 2.27
Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. Urology (2011) 2.26
Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol (2006) 2.20
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology (2013) 2.08
Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology (2011) 2.06
Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 2.06
Regional differences in early stage bladder cancer care and outcomes. Urology (2010) 2.03
Use of ureteroscopy before and after expansion of lithotripter ownership in Michigan. Urology (2011) 2.03
Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med (2012) 2.00
Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer (2007) 2.00
Opening of ambulatory surgery centers and procedure use in elderly patients: data from Florida. Arch Surg (2011) 1.94
Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer (2005) 1.93
Delays in diagnosis and bladder cancer mortality. Cancer (2010) 1.92
Matched comparison of robotic-assisted and open radical cystectomy. Urology (2012) 1.84
Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol (2003) 1.83
Patient education materials about the treatment of early-stage prostate cancer: a critical review. Ann Intern Med (2004) 1.71
Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. J Urol (2009) 1.68
Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. J Urol (2011) 1.64
Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med (2012) 1.64
Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. J Urol (2008) 1.64
Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol (2005) 1.63
Impact of surgical volume on mortality and length of stay after nephrectomy. Urology (2004) 1.62
Long-term patient reported outcome and satisfaction after oral mucosa graft urethroplasty for hypospadias. J Urol (2005) 1.62
Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy. Cancer (2008) 1.60
Understanding the variation in treatment intensity among patients with early stage bladder cancer. Cancer (2010) 1.59
Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology (2013) 1.58
Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. Am J Epidemiol (2002) 1.58
Patterns of care for early stage bladder cancer. Cancer (2010) 1.57
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res (2012) 1.57
Trends in medical expulsive therapy use for urinary stone disease in U.S. emergency departments. Urology (2009) 1.56
Understanding bladder cancer death: tumor biology versus physician practice. Cancer (2009) 1.55
Intraoperative nerve stimulation with measurement of urethral sphincter pressure changes during radical retropubic prostatectomy: a feasibility study. J Urol (2003) 1.55
Hospitalization trends after prostate and bladder surgery: implications of potential payment reforms. J Urol (2012) 1.54
Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. J Urol (2012) 1.52
The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. J Urol (2013) 1.52
Inguinal bladder hernia masking bowel ischemia. Urology (2004) 1.49
A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol (2013) 1.48
Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison. Urology (2002) 1.47
Use of nephrectomy at select medical centers--a case of follow the crowd? J Urol (2006) 1.47
The regionalization of radical cystectomy to specific medical centers. J Urol (2005) 1.47
The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol (2003) 1.46